Children’s cancer drug shortage should ease, FDA says, but doctors, parents worry it’ll recur
TRENTON, N.J. — A severe shortage of a childhood cancer drug should ease before hospitals run out of it in a couple weeks, a top federal regulator said Tuesday. But the companies that make the drug are giving few details about how they will find a long-term solution to end the problem.